Back to Search
ADAM PETTITT, PHD
PHD
Counseling Psychologist
NPI: 1902799463Individual
Specialties, Licenses & Credentials
Counseling PsychologistPrimary
Psychologist — Counseling
Code: 103TC1900X
Research & Publications (20)
Treatment of B-cell chronic lymphocytic leukemia with nonchemotherapeutic agents: experience with single-agent and combination therapy.
PMID 18987653·Leukemia·2009
6-review
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome.
PMID 19066328·Haematologica·2009
8-other
A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 gene.
PMID 19491257·Cancer Res·2009
8-other
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
PMID 18559621·Clin Cancer Res·2008
4-observational
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.
PMID 18758461·Nat Genet·2008
8-other
Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission.
PMID 18582835·Lancet Infect Dis·2008
6-review
Multivariate Markov process models for the transmission of methicillin-resistant Staphylococcus aureus in a hospital ward.
PMID 18047536·Biometrics·2008
4-observational
Glucocorticoid-based combination therapy for chronic lymphotic leukemia: new tricks for an old dog.
PMID 18949606·Leuk Lymphoma·2008
6-review
Using samples to estimate the sensitivity and specificity of a surveillance process.
PMID 18510466·Infect Control Hosp Epidemiol·2008
8-other
Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
PMID 17982489·Oncogene·2008
8-other
The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.
PMID 17568813·Leukemia·2007
6-review
The development of sarcoidosis with the use of alemtuzumab - clues to T-cell immune reconstitution.
PMID 17587337·Br J Haematol·2007
5-case
Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models.
PMID 17360254·J R Soc Interface·2007
8-other
A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions.
PMID 17188714·J Theor Biol·2007
8-other
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.
PMID 17658394·Lancet·2007
4-observational
Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data.
PMID 16926230·Biostatistics·2007
8-other
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects.
PMID 16738694·Leukemia·2006
8-other
Bayesian modelling of an epidemic of severe acute respiratory syndrome.
PMID 16802088·Bull Math Biol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1551 PEARL ST
EUGENE, OR 97401 - Phone
- (541) 517-9733
Quick Facts
- NPI
- 1902799463
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile